Source Genomics has extensive experience across both research and clinical development and supports every stage of the process—from early-stage studies and translational research to clinical trials and diagnostic testing. The organisation works closely with academic institutions, biotechnology and biopharmaceutical companies, and contract research organisations (CROs) to deliver high-quality genomic services that drive innovation across multiple therapeutic areas.
Source Genomics provides a comprehensive range of genomic services using state-of-the-art technologies, including Illumina NovaseqX Plus, NextSeq500, MiSeq, Oxford Nanopore Technologies, and the Element Biosciences AVITI™ System. Its capabilities span whole genome sequencing, whole exome sequencing, RNA sequencing, gene expression analysis, and advanced multi-omics techniques. Whether researchers are seeking detailed cellular insights through single-cell and spatial analysis or conducting genome-wide studies, Source BioScience delivers the expertise and technology to support both research and clinical applications.
